The Adventist Health System has named Terry Shaw as the organization’s new president and chief executive officer. Shaw will immediately assume leadership responsibilities for the faith-based health care system.
The system includes 46 hospital campuses in 10 states, as well as a host of urgent care centers, home health and hospice agencies, physician practices and skilled nursing facilities.
Shaw’s career with Adventist Health System spans more than 30 years. Immediately prior to being named president/CEO, he served as executive vice president, chief financial officer and chief operations officer, where his grasp of healthcare finance, IT and overall operations enabled him to help define the organization’s vision and direction.
He began his career with AHS as a business intern in 1982. He was appointed director at Florida Hospital in 1985, assistant vice president in 1990, vice president in 1992 and senior vice president in 1996. In 2000, Shaw became senior vice president and chief financial officer for AHS, a role he held until 2010 when he gained COO responsibilities.
Shaw received bachelor’s degrees in accounting and computer science from Southern Adventist University, and a master’s degree in administration from the University of Central Florida.
He currently serves as vice chairman of the Premier board of directors and is a member of the Hospital Financial Management Association, American College of Healthcare Executives and State of Texas Board of Certified Accountants. As a silver level Leadership Society contributor to the United Way, Shaw supports and donates to the nonprofit organization, and is also active with several other professional and service organizations.
He and his wife, Paula, reside in Orlando, Florida and have two adult sons. Don Jernigan, who officially retired as Adventist Health System’s president/CEO on Dec. 8 after leading the organization for more than a decade, will transition to a faculty role at the Adventist Health System Leadership Institute.
By Jeff Lagasse
Source: Healthcare Finance
Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.
Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.
The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).
